Who’s Going to Cell 2026

Nov 12–13, 2026 London, UK ~800 attendees Website

109 organizations and 115 speakers at Cell 2026, an ~800-person, mostly industry meeting of cell culture, cell-line development and cell therapy manufacturing scientists. As of Oct 8, 2026.

Showing 1–9 of 109 organizations

Organization	Cell 2026 Attendance
Bristol Myers Squibb Princeton, New Jersey
bms.com Large pharma Global drugmaker with marketed CAR-T cell therapies alongside medicines for cancer, immunology and cardiovascular disease.	Talk Thu Nov 12 9:25am–9:50am Advanced Technologies Driving The Next Wave Of Gene Therapy Cell and gene therapy Talk Thu Nov 12 10:15am–10:40am Phase Appropriate Analytical Strategies Including Comparability Analytics and characterizationManufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm Quality Control Strategies In Advanced CGTs with Quell Therapeutics, University of Liverpool Cell and gene therapyAnalytics and characterization Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? with Johnson & Johnson, AstraZeneca Cell and gene therapy Talk Thu Nov 12 4:55pm–5:20pm From Vision And Concepts To Practical Execution - An Analytical Strategy And Lifecycle Execution Roadmap To Support Commercial Readiness And Operational Execution Success Analytics and characterizationManufacturing and CMC Talk Thu Nov 12 5:20pm–5:45pm One Lot, One Life: Scaling Hope for Patients with Autologous CART Treatments Cell and gene therapyManufacturing and CMC Talk Fri Nov 13 1:55pm–2:20pm Designing An End-To-End Supply Chain For CGTs Cell and gene therapyManufacturing and CMC
AstraZeneca Cambridge, UK
astrazeneca.com Large pharma Global drugmaker with medicines in oncology, cardiovascular, respiratory, immunology and rare disease, and a cell therapy pipeline.	Panel Thu Nov 12 12:25pm–12:50pm Cracking In Vivo Delivery For Next-Generation Gene Therapies with University Medical Center Freiburg, SymphoRNA, AviadoBio Cell and gene therapy Panel Thu Nov 12 12:25pm–12:50pm The Productivity Challenge: How Can The Industry Deliver More Medicines With Less with UCB Manufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? with Bristol Myers Squibb, Johnson & Johnson Cell and gene therapy Talk Thu Nov 12 3:05pm–3:30pm Mapping Immune Vulnerabilities: CRISPR Screens for Target Discovery Stem cells, organoids and cell models Talk Fri Nov 13 3:10pm–3:35pm Cell Line Database Development Cell line developmentDigital biomanufacturing and AI Talk Fri Nov 13 3:50pm–4:15pm Clinical Trial Designs For Advanced Therapies Outside Of Oncology Cell and gene therapy Talk Fri Nov 13 4:15pm–4:40pm Reduction Of Animal Bi-Products In Cell Cultures Cell culture and upstream processing
Cell and Gene Therapy Catapult London, UK
ct.catapult.org.uk Gov/NGO UK innovation centre helping cell and gene therapy developers with process development, GMP manufacturing space and regulatory support.	Talk Thu Nov 12 3:05pm–3:30pm Enabling Affordable Gene Therapies Through Continuous Viral Vector Manufacturing Cell and gene therapyManufacturing and CMC Talk Thu Nov 12 5:45pm–6:10pm From Academia To Clinical Trials: A Collaborative Journey Between CGT Catapult And X Therapeutics For Successful Development And Delivery Of ATMPs Cell and gene therapy Talk Fri Nov 13 9:25am–9:50am rAAV Production Process Intensification Using Perfusion Bioreactor Technology Cell and gene therapyCell culture and upstream processing Talk Fri Nov 13 1:55pm–2:20pm Regulatory Initiatives For ATMPs In The UK Cell and gene therapy Panel Fri Nov 13 4:40pm–5:05pm Beyond Silos: How Cell & Gene Therapies Fit Into The Broader Biotech & Treatment Landscape with Resolution Therapeutics, Leucid Bio Cell and gene therapy
Resolution Therapeutics London, UK
resolution-tx.com Biotech Develops regenerative macrophage therapies for inflammatory and fibrotic diseases, led by a programme in end-stage liver disease.	Talk Thu Nov 12 10:15am–10:40am Building For The Future: Phase-Appropriate CMC Strategies Manufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm The AI Reality Check: What’s Ready Now, What Isn’t, And How Do We Validate It Safely? with Hogan Lovells, TreeFrog Therapeutics Digital biomanufacturing and AI Panel Fri Nov 13 4:40pm–5:05pm Beyond Silos: How Cell & Gene Therapies Fit Into The Broader Biotech & Treatment Landscape with Cell and Gene Therapy Catapult, Leucid Bio Cell and gene therapy Panel Fri Nov 13 4:40pm–5:05pm Navigating The Regulatory Lifecycle Of Advanced Therapies: From Platform Approval To Manufacturing & Post-Market Evidence with Aspen Neuroscience, NHS Blood and Transplant Cell and gene therapyManufacturing and CMC Talk Fri Nov 13 5:05pm–5:30pm Developing A Regenerative Macrophage Therapy (RMT) For Fibro-Inflammatory Diseases: Challenges And Opportunities Cell and gene therapy
NHS
nhs.uk Gov/NGO The UK's publicly funded health service, whose hospitals run clinical trials and deliver approved cell and gene therapies.	Panel Thu Nov 12 5:45pm–6:10pm Solving the Capacity Crunch: How Do We Scale Advanced Therapy Operations Without Compromising Quality? Cell and gene therapyManufacturing and CMC Panel Fri Nov 13 2:45pm–3:10pm From Approval To Access: Why Cell & Gene Therapies Still Don’t Reach Patients with EMEUNET, John Radcliffe Hospital Cell and gene therapy Talk Fri Nov 13 3:50pm–4:15pm CAR-T Clinical Trials In Hospitals Cell and gene therapy Talk Fri Nov 13 4:40pm–5:05pm Patient Access In Hospitals To Administer Cell & Gene Therapies Cell and gene therapy
TreeFrog Therapeutics Bordeaux, France
treefrog.fr Biotech Develops cell therapies from pluripotent stem cells grown in its C-Stem 3D encapsulation platform, with a lead program in Parkinson's disease.	Panel Thu Nov 12 2:40pm–3:05pm The AI Reality Check: What’s Ready Now, What Isn’t, And How Do We Validate It Safely? with Hogan Lovells, Resolution Therapeutics Digital biomanufacturing and AI Panel Fri Nov 13 9:25am–9:50am Plenary Thought Leadership Panel Discussion: Turning Scientific Breakthroughs Into Sustainable Therapies – Building A Viable Business Model For CGTs with Orchard Therapeutics Cell and gene therapy Talk Fri Nov 13 11:40am–12:05pm Bridging Development and Manufacturing Through Predictive Scaling Manufacturing and CMCCell culture and upstream processing Talk Fri Nov 13 2:45pm–3:10pm Cell Therapy: From Therapeutic Potential To Sustainable Patient Access Cell and gene therapy
Autolus London, UK
autolus.com Biotech Develops and markets CAR-T cell therapies, including an approved treatment for adult acute lymphoblastic leukaemia.	Talk Thu Nov 12 3:05pm–3:30pm Harnessing Digital PCR For Rapid Sterility Testing Analytics and characterization Panel Thu Nov 12 5:20pm–5:45pm Overcoming Sterility Testing Challenges In CGT Analytical Development Analytics and characterizationCell and gene therapy Talk Fri Nov 13 5:05pm–5:30pm Developing Cutting-Edge Flow-Based Assays For Critical CMC Applications Analytics and characterizationManufacturing and CMC
AviadoBio London, UK
aviadobio.com Biotech King's College London spin-out developing gene therapies for neurodegenerative diseases such as frontotemporal dementia.	Panel Thu Nov 12 12:25pm–12:50pm Cracking In Vivo Delivery For Next-Generation Gene Therapies with University Medical Center Freiburg, SymphoRNA, AstraZeneca Cell and gene therapy Talk Thu Nov 12 2:40pm–3:05pm Manufacture Of AVB-406, A BBB-Crossing AAV Vector For MAPT Knockdown In Alzheimer's Disease Cell and gene therapyManufacturing and CMC Talk Thu Nov 12 5:45pm–6:10pm Leveraging Platform-Based RNA Silencing To Accelerate Rare Disease Therapeutic Development Cell and gene therapy
Hogan Lovells London, UK
hoganlovells.com Consulting & services International law firm advising life sciences companies on regulatory, intellectual property and transactional matters.	Panel Thu Nov 12 2:40pm–3:05pm The AI Reality Check: What’s Ready Now, What Isn’t, And How Do We Validate It Safely? with TreeFrog Therapeutics, Resolution Therapeutics Digital biomanufacturing and AI Talk Fri Nov 13 12:05pm–12:30pm Changing Regulatory Environment For CGTs In 2027 (SoHO Regulations) Cell and gene therapy Talk Fri Nov 13 3:10pm–3:35pm Featured Session: AI In Decision-Making - EU's AI Perspective Digital biomanufacturing and AI

Instantly find 20 buyers from companies at Cell 2026

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

When and where is Cell 2026?

Cell 2026 (Cell Culture, Cell Line Development & Cell and Gene Therapy) runs November 12–13, 2026, at Novotel London West in London, UK.

Where is the Cell 2026 program?

This guide lists every organization on the Cell 2026 program with its sessions; the full program is on the official website.

How do I register for Cell 2026?

Fees and registration are on the organizer's registration page.

What conference is this?

Cell 2026 is a London meeting on cell culture, cell line development and cell and gene therapy, held November 12–13, 2026 at the Novotel London West. It brings together cell culture, cell-line development and cell and gene therapy manufacturing scientists from biopharma and academia with the bioprocess equipment, media, reagent and CDMO companies that serve them.

What is in this guide?

Every organization we can place at Cell 2026: 115 speakers from the public agenda (120 talks, keynotes, panels and sponsored presentations) rolled up to their companies and institutions, and the 48 sponsors with their level — 109 organizations in one list. Speakers appear as job titles, never by name. The organizers publish no attendee list and no booth numbers.

How are organizations typed?

By the role an organization plays in making cell-based and biologic products: drug developers (large pharma and biotech), then CDMOs and CROs, equipment and consumables suppliers, analytics and instrument makers, software and automation companies, and consultancies and other services — and academic, government and non-profit bodies. The topic filters are judged from each session’s title.

How current is it?

Pulled from the public agenda, speaker list and sponsor list on October 8, 2026, about five weeks before the meeting. The organizers add speakers and sponsors until the meeting.

Browse Cell 2026 by

Organization type

Topic

Everyone

All organizations A–Z 109

Organizations with their own page

84 organizations — every exhibitor and every organization with 2 or more presentations.

Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction